T1	Participants 98 144	advanced, suboptimally debulked ovarian cancer
T2	Participants 147 222	176 eligible patients with advanced suboptimally operated ovarian carcinoma
T3	Participants 924 989	Thirty-seven platinum-resistant and 27 platinum-sensitive tumours
T4	Participants 1256 1296	Patients with platinum-sensitive tumours
T5	Participants 1958 1983	Patients with recurrences